Clinical Ophthalmology, 2016 Jie Shen,1 Marina Bejanian2 1Department of Translational Sciences, 2Department of Ophthalmology Clinical Development, Allergan plc, Irvine, CA, USA Purpose: Many patients with glaucoma require combination therapies to achieve target intraocular ...
Shen J, Bejanian M
doaj
Определение сопутствующих примесей в глазных каплях пролонгированного действия на основе тимолола хроматографическими методами [PDF]
, 2013 ГЛАЗНЫЕ КАПЛИТИМОЛОЛХРОМАТОГРАФИЯ ТОНКОСЛОЙНАЯХРОМАТОГРАФИЯ ...
Жебентяев, А. И. +3 more
core
Degradation kinetics of azirdinyl quinoid antitumour agents [PDF]
, 1985 Beijen, J.H. +5 more
core +2 more sources
Estudio galénico de los medicamentos utilizados en España para el tratamiento del Glaucoma [PDF]
, 2018 La presión intraocular elevada es el principal factor de riesgo implicado en el desarrollo del glaucoma, segunda causa de ceguera irreversible a nivel mundial según la OMS.
Lafita Llorca, Carlos Javier
core
Twenty-four hour efficacy of glaucoma medications [PDF]
, 2015 Katsanos, Andreas +5 more
core +1 more source
Fixed-Dose Combination of Tafluprost and Timolol in the Treatment of Open-Angle Glaucoma and Ocular Hypertension: Comparison with Other Fixed-Combination Products [PDF]
, 2014 core +1 more source
Low-concentration bimatoprost 0.01% and timolol 0.1% eye gel versus bimatoprost 0.03% and timolol 0.5% eye drops in open-angle glaucoma or ocular hypertension: a phase III randomised study. [PDF]
Br J OphthalmolCordeiro MF +6 more
europepmc +1 more source
All Eyes on Hyperkalemia: A Case Report of Timolol Ophthalmic Drops Leading to Hyperkalemia. [PDF]
Kidney MedDwilow M +4 more
europepmc +1 more source
Efficacy and safety of preservative-free versus preserved timolol eye drops in glaucoma: A randomized crossover study. [PDF]
J Chin Med AssocKo YH +6 more
europepmc +1 more source